Apligraf, Factory-Grown Living Tissue, Heals Chronic Wounds
It’s amazing to see the advancements in the field of biotechnology! Organogenesis Inc. is a world leading company specializing in bio-active chronic wounds healing, oral regeneration and bio-surgery. They have marketed a product called Apligraf; FDA-approved to treat two types of chronic wounds—venous leg ulcers and diabetic foot ulcers.
Apligraf is made up of, “a matrix of cow collagen, human fibroblasts and keratinocyte stem cells (from discarded circumcisions)." The bilayered skin substitute is applied to chronic wounds; such as diabetic foot ulcers, venous leg ulcers and pressure ulcers.
In the clinical trials, Apligraf healed diabetic foot ulcers 100% in twelve weeks! That is good news to the 600,000-800,000 diabetics in the United States, who suffer from foot ulcers.
Apligraf is made up of, “a matrix of cow collagen, human fibroblasts and keratinocyte stem cells (from discarded circumcisions)." The bilayered skin substitute is applied to chronic wounds; such as diabetic foot ulcers, venous leg ulcers and pressure ulcers.
In the clinical trials, Apligraf healed diabetic foot ulcers 100% in twelve weeks! That is good news to the 600,000-800,000 diabetics in the United States, who suffer from foot ulcers.
Trend Themes
1. Biotechnology Advancements - The advancements in biotechnology are providing innovative solutions for chronic wounds healing.
2. Living Tissue Therapy - The use of living tissue therapy, such as Apligraf, is revolutionizing the treatment of chronic wounds.
3. Regenerative Medicine - Regenerative medicine techniques, like Apligraf, are offering new possibilities for wound healing and tissue regeneration.
Industry Implications
1. Biotechnology - The biotechnology industry has the potential to develop and commercialize advanced therapies for chronic wounds healing.
2. Medical Devices - The medical devices industry can explore opportunities to create innovative wound healing solutions using living tissue technology.
3. Pharmaceuticals - The pharmaceutical industry can leverage regenerative medicine approaches, such as Apligraf, to develop treatments for chronic wounds.
4.7
Score
Popularity
Activity
Freshness
